Miami Cancer Institute Celebrates Successful Hosting and Completion of the 60th Annual Meeting of PTCOG
“Proton radiotherapy is now a treatment option with a more defined space in multidisciplinary cancer care.
This encourages us to move forward from dosimetriv evaluations, case studies, and retrospective reports to well-conducted prospective clinical trials, with much higher levels of evidence backing up the value of this modality. It is exciting to know that we are producing real-world evidence demonstrating not only the clinical benefits but also the cost-effectiveness of our treatments,” shared Minesh Mehta, M.D., Deputy Director and Chief of Radiation Oncology at Miami Cancer Institute.
During the conference, attendees from across the world participated in discussions, debates, lectures, posters, and scientific presentations regarding advances in the field of particle beam radiotherapy. Baptist Health South Florida designated this as a live activity for a maximum of 17 AMA PRA Category 1 Credits™, approved by the Florida Board of Medicine.
“At Miami Cancer Institute, we provide a comprehensive range of all major radiotherapy modalities and have effectively integrated them into a multidisciplinary clinical-trial oriented cancer matrix. This is representative of the robust integration of proton therapy into mainstream cancer management,” shared Michael Zinner, M.D., and Chief Executive Officer at Miami Cancer Institute. “It is a privilege to be the host of this year’s meeting and highlight the great work in radiation oncology aiding those in South Florida, and globally.”
To learn more about the PTCOG, feel free to visit here.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.
Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with 12 hospitals, more than 24,000 employees, 4,000 physicians and 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.
###
